Safe prescribing of metformin in diabetes

13Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

Abstract

Metformin is the first-line pharmacological therapy for type 2 diabetes. It is the only glucose-lowering oral drug that has been shown to reduce mortality in patients with diabetes. The most common adverse effect is gastrointestinal upset. Starting at a low dose and increasing it slowly reduces this risk. Taking metformin with food also helps. Numerous contraindications to the use of metformin are listed in the product information, including reduced renal function. Strict adherence to these recommendations may deny a valuable drug to many patients.

Cite

CITATION STYLE

APA

Davoren, P. (2014). Safe prescribing of metformin in diabetes. Australian Prescriber, 37(1), 2–5. https://doi.org/10.18773/austprescr.2014.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free